When it comes to rare diseases, parents, caregivers, and patient groups are often forced to become citizen-scientists and drug developers to identify and advance therapeutic candidates.
When it comes to rare diseases, parents, caregivers, and patient groups are often forced to become citizen-scientists and drug developers to identify and advance therapeutic candidates.